Defense Advanced Research Projects AgencyTagged Content List

Medical Devices

Relating to non-pharmacologic interventions to diagnose, prevent or treat disease or injury

Showing 8 results for Med-Devices + Analytics RSS
February 12, 2019,
Executive Conference Center
The Biological Technologies Office is holding a Proposers Day meeting to provide information to potential proposers on the objectives of the new Measuring Biological Aptitude (MBA) program. MBA aims to improve how the individual warfighter identifies, measures, and tracks personalized biomarkers throughout his or her career to help achieve new levels of performance for specialized roles. MBA technologies could improve training, team formation, mission performance, and post-mission recovery, yielding a better prepared, more effective, more resilient force.
The Epigenetic CHaracterization and Observation (ECHO) program aims to diminish the threat posed by weapons of mass destruction (WMD). To do this, the program is building a man-portable device that analyzes an individual’s epigenetic “fingerprint” to potentially reveal a detailed history of that individual’s exposure to WMD or their precursors. DARPA envisions that the same technology could provide rapid diagnostics for troops who may have been exposed to threat agents or who may be suffering from infections, providing a timely signal to apply effective medical countermeasures.
Whereas the tools and weapons that are used by our warfighters have evolved dramatically in the past few decades, the way in which the warfighter is prepared has not kept pace with those developments. The Measuring Biological Aptitude (MBA) program aims to address the need for a more capable fighting force by helping individual warfighters identify, measure, and track personalized biomarkers related to training and peak performance for specialized roles. If the program succeeds, MBA technologies will give warfighters the ability to understand the underlying biological processes that govern their performance.